Alcohol Withdrawal Management

First-Line Treatment Agents

The American Association for the Study of Liver Diseases recommends benzodiazepines as the gold standard first-line treatment for alcohol withdrawal syndrome, with long-acting agents preferred for most patients due to superior protection against seizures and delirium tremens through gradual self-tapering 1, 2, 3
For most patients, long-acting benzodiazepines, such as chlordiazepoxide or diazepam, are recommended as they provide better protection against seizures and delirium tremens compared to shorter-acting agents 1, 2, 3

The American College of Physicians recommends switching to intermediate-acting benzodiazepines, such as lorazepam or oxazepam, in patients with advanced age, hepatic dysfunction, or severe medical comorbidities 1, 2, 3
Lorazepam dosing for severe alcohol withdrawal syndrome starts at 6-12 mg/day, then tapers following resolution of withdrawal symptoms 3

The American Society of Addiction Medicine recommends using symptom-triggered dosing over fixed-dose schedules to prevent drug accumulation while ensuring adequate symptom control 2
Employ the Clinical Institute Withdrawal Assessment for Alcohol scale to guide treatment intensity, with a score >8 indicating moderate alcohol withdrawal syndrome requiring pharmacological intervention, and a score ≥15 indicating severe alcohol withdrawal syndrome requiring aggressive treatment 2, 3, 4

The National Institute on Alcohol Abuse and Alcoholism recommends oral thiamine 100-300 mg/day for standard cases, and parenteral thiamine for high-risk patients or suspected Wernicke's encephalopathy 2, 3, 4
Thiamine should be given immediately when Wernicke's encephalopathy is suspected to prevent irreversible neurological damage 3

The American Academy of Emergency Medicine recommends monitoring vital signs and withdrawal symptoms frequently, especially during the first 72 hours, when symptoms peak at 3-5 days post-cessation 2, 3
Adjust medication dosing based on symptom severity using Clinical Institute Withdrawal Assessment for Alcohol scores 2

The Society of Hospital Medicine recommends admitting patients to an inpatient setting if they are at risk of severe withdrawal complications, have concurrent serious physical or psychiatric disorders, or have inadequate social support or lack of reliable supervision 2, 3

The European Association for the Study of the Liver suggests that baclofen shows promise for both alcohol withdrawal syndrome treatment and relapse prevention, although more research is needed 1
Sodium oxybate and carbamazepine or gabapentin may be used for mild symptoms or as adjunctive therapy, but lack sufficient evidence to replace benzodiazepines as first-line therapy 1